Abstract
Background
The high prevalence of obstructive sleep apnea syndrome (OSAS) in children with Down syndrome (DS) has been attributed to a reduced upper airway size, while the role of ventilatory control is unclear. The objectives of our case–control study were to evaluate the upper airway reduction in children with DS and moderate to severe OSAS as compared to typically developing (TD) children with similar OSAS severity and to evaluate the degree of chemical loop gain modifications including its components: controller and plant gains (CG, PG).
Methods
Thirteen children with DS were matched for age, sex, OSAS severity and ethnicity with 26 TD children. They had undergone acoustic rhinometry and pharyngometry, chemical LG obtained during awake tidal breathing measurement and hypercapnic–hyperoxic ventilatory response testing.
Results
As compared to TD, children with DS depicted reduced oropharyngeal dimensions, significantly lower CG and LG and no different PG. Their hypercapnic ventilatory response slopes were not different.
Conclusions
We concluded that the decreased CG in DS was related to decreased peripheral chemoreceptor sensitivity, and while central chemosensitivity was normal, the former explained the increased end-tidal PCO2 observed in children with DS as compared to TD. Pharyngeal dimensions are reduced in children with DS and OSAS.
Impact
-
Reduced upper airway size and nocturnal alveolar hypoventilation in children with Down syndrome (DS) have been previously reported.
-
We confirmed that children with DS and moderate-to-severe OSA have reduced oropharyngeal size as compared to typically developing children with similar OSAS severity and demonstrated decreased peripheral chemosensitivity explaining the alveolar hypoventilation observed in children with DS.
-
Central chemosensitivity appears to be intact in children with DS and moderate to severe OSAS
-
Our results support growing evidence that Down syndrome is associated with autonomic nervous system dysfunction.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon request. The data are not publicly available because they contain information that may compromise the privacy of the research participants.
References
Kaditis, A. G. et al. Obstructive sleep disordered breathing in 2- to 18-year-old children: diagnosis and management. Eur. Respir. J. 47, 69–94 (2016).
Lee, C.-F., Lee, C.-H., Hsueh, W.-Y., Lin, M.-T. & Kang, K.-T. Prevalence of obstructive sleep apnea in children with Down syndrome: a meta-analysis. J. Clin. Sleep Med. 14, 867–875 (2018).
Loane, M. et al. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur. J. Hum. Genet. 21, 27–33 (2013).
Uong, E. C. et al. Magnetic resonance imaging of the upper airway in children with Down syndrome. Am. J. Respir. Crit. Care Med. 163, 731–736 (2001).
Siriwardhana, L. S. et al. Children with down syndrome and sleep disordered breathing display impairments in ventilatory control. Sleep Med. 77, 161–169 (2021).
Younes, M. CrossTalk proposal: elevated loop gain is a consequence of obstructive sleep apnoea. J. Physiol. 592, 2899–2901 (2014).
Amin, R. & Khoo, M. Loop gain in paediatric sleep-disordered breathing: a different story from adults. Respirology 25, 1119–1120 (2020).
Bokov, P., Matrot, B., Gallego, J. & Delclaux, C. Comparison of methods of chemical loop gain measurement during tidal ventilation in awake healthy subjects. J. Appl. Physiol. 125, 1681–1692 (2018).
Spengler, C. M., Czeisler, C. A. & Shea, S. A. An endogenous circadian rhythm of respiratory control in humans. J. Physiol. 526, 683–694 (2000).
Gederi, E. et al. Model-based estimation of loop gain using spontaneous breathing: a validation study. Respir. Physiol. Neurobiol. 201, 84–92 (2014).
Ream, R. S. et al. Volumetric capnography in children influence of growth on the alveolar plateau slope. Anesthesiology 82, 64–73 (1995).
Read, D. C. A clinical method for assessing the ventilatory response to carbon dioxide. Australas. Ann. Med. 16, 20–32 (1967).
Duffin, J. Measuring the ventilatory response to hypoxia. J. Physiol. 584, 285–293 (2007).
Berry, R. B. et al. AASM Scoring Manual Updates for 2017 (Version 2.4). J. Clin. Sleep Med. 13, 665–666 (2017).
Villa, M. P. et al. Sleep clinical record: an aid to rapid and accurate diagnosis of paediatric sleep disordered breathing. Eur. Respir. J. 41, 1355–1361 (2013).
Bokov, P. et al. Prevalence of mouth breathing, with or without nasal obstruction, in children with moderate to severe obstructive sleep apnea. Sleep Med. 98, 98–105 (2022).
Friedman, M., Ibrahim, H. & Joseph, N. J. Staging of obstructive sleep apnea/hypopnea syndrome: a guide to appropriate treatment. Laryngoscope 114, 454–459 (2004).
Brodsky, L. Modern assessment of tonsils and adenoids. Pediatr. Clin. North Am. 36, 1551–1569 (1989).
Cassano, P., Gelardi, M., Cassano, M., Fiorella, M. L. & Fiorella, R. Adenoid tissue rhinopharyngeal obstruction grading based on fiberendoscopic findings: a novel approach to therapeutic management. Int. J. Pediatr. Otorhinolaryngol. 67, 1303–1309 (2003).
Bokov, P. et al. The utility of acoustic pharyngometry and rhinometry in pediatric obstructive sleep apnea syndrome. Sleep Med. 58, 75–81 (2019).
Breslow, N. Design and analysis of case-control studies. Annu. Rev. Public Health 3, 29–54 (1982).
Snow, A. et al. Severe hypersomnolence after pituitary/hypothalamic surgery in adolescents: clinical characteristics and potential mechanisms. Pediatrics 110, e74–e74 (2002).
Conners, C. K. Conners’ Abbreviated Symptom Questionnaire (Multi-Health Systems, 1990).
Brouilette, R. et al. A diagnostic approach to suspected obstructive sleep apnea in children. J. Pediatr. 105, 10–14 (1984).
Spruyt, K. & Gozal, D. Screening of pediatric sleep-disordered breathing: a proposed unbiased discriminative set of questions using clinical severity scales. Chest 142, 1508–1515 (2012).
Nguyên, X.-L., Lévy, P., Beydon, N., Gozal, D. & Fleury, B. Performance characteristics of the French version of the severity hierarchy score for paediatric sleep apnoea screening in clinical settings. Sleep Med. 30, 24–28 (2017).
Zemel, B. S. et al. Growth charts for children with Down syndrome in the United States. Pediatrics 136, e1204–e1211 (2015).
Torfs, C. P. & Christianson, R. E. Anomalies in Down syndrome individuals in a large population-based registry. Am. J. Med. Genet. 77, 431–438 (1998).
Carroll, K. N., Arbogast, P., Dudley, J. A. & Cooper, W. O. Increase in incidence of medically-treated thyroid disease in children with Down syndrome following re-release of American Academy of Pediatrics Health Supervision Guidelines. Pediatrics 122, e493–e498 (2008).
Eckert, D. J. Phenotypic approaches to obstructive sleep apnoea – new pathways for targeted therapy. Sleep Med. Rev. 37, 45–59 (2018).
Strollo, P. J. et al. Upper-airway stimulation for obstructive sleep apnea. N. Engl. J. Med. 370, 139–149 (2014).
Caloway, C. L. et al. Update on hypoglossal nerve stimulation in children with down syndrome and obstructive sleep apnea. Laryngoscope 130, E263–E267 (2020).
Op de Beeck, S. et al. Endotypic mechanisms of successful hypoglossal nerve stimulation for obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 203, 746–755 (2021).
Khoo, M. C. & Marmarelis, V. Z. Estimation of peripheral chemoreflex gain from spontaneous sigh responses. Ann. Biomed. Eng. 17, 557–570 (1989).
Smith, C. A., Blain, G. M., Henderson, K. S. & Dempsey, J. A. Peripheral chemoreceptors determine the respiratory sensitivity of central chemoreceptors to CO2: role of carotid body CO2. J. Physiol. 593, 4225–4243 (2015).
Richard, N. et al. Nocturnal hypoventilation in Down syndrome children with or without sleep apnea. Pediatr. Pulmonol. 55, 1246–1253 (2020).
Guazzi, M. & Freis, E. D. Sino-aortic reflexes and arterial pH, PO2, and PCO2 in wakefulness and sleep. Am. J. Physiol. 217, 1623–1627 (1969).
O’Driscoll, D. M. et al. Cardiac and sympathetic activation are reduced in children with Down syndrome and sleep disordered breathing. Sleep 35, 1269–1275 (2012).
Santoro, J. D. et al. Diminished blood pressure profiles in children with Down syndrome. Hypertension 75, 819–825 (2020).
Finley, J. C. & Katz, D. M. The central organization of carotid body afferent projections to the brainstem of the rat. Brain Res. 572, 108–116 (1992).
Koshiya, N. & Guyenet, P. G. NTS neurons with carotid chemoreceptor inputs arborize in the rostral ventrolateral medulla. Am. J. Physiol. 270, R1273–R1278 (1996).
Colvin, K. L. & Yeager, M. E. What people with Down Syndrome can teach us about cardiopulmonary disease. Eur. Respir. Rev. 26, 160098 (2017).
Khoo, M. C. K., Hu, W.-H. & Amin, R. Effects of ventilation-perfusion mismatch on severity of obstructive sleep apnea: A Modeling Study. In 2020 42nd Annual International Conference of the IEEE Engineering in Medicine Biology Society (EMBC) 2792–2795 (IEEE, 2020).
Borker, P. V. et al. Non-REM apnea and hypopnea duration varies across population groups and physiologic traits. Am. J. Respir. Crit. Care Med. 203, 1173–1182 (2021).
Maris, M. et al. Drug-induced sedation endoscopy in surgically naive children with Down syndrome and obstructive sleep apnea. Sleep Med. 24, 63–70 (2016).
Ioan, I. et al. Neurocognitive evaluation of children with down syndrome and obstructive sleep apnea syndrome. Sleep Med. 100, 542–549 (2022).
Howard, J. J. M. et al. Outcomes in children with Down syndrome and mild obstructive sleep apnea treated non-surgically. Laryngoscope 130, 1828–1835 (2020).
Edwards, B. A. et al. Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea. J. Physiol. 590, 1199–1211 (2012).
Taranto-Montemurro, L. et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. a randomized, placebo-controlled, double-blind crossover trial. Am. J. Respir. Crit. Care Med. 199, 1267–1276 (2019).
Duffin, J. Measuring the respiratory chemoreflexes in humans. Respir. Physiol. Neurobiol. 177, 71–79 (2011).
Saunders, N. A., Heilpern, S. & Rebuck, A. S. Relation between personality and ventilatory response to carbon dioxide in normal subjects: a role in asthma? Br. Med. J. 1, 719–721 (1972).
Author information
Authors and Affiliations
Contributions
P.B. conceived and designed the research; P.B., I.B., J.D., and C.D. performed the measurements; P.B. and C.D. analyzed the data; all authors interpreted results of the experiments; P.B. prepared the figures; P.B., B.D., and C.D. drafted the manuscript; all authors edited and revised the manuscript; all authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
A written consent was not required from the included subjects. The subjects and their parents were informed of the collection of their prospective data for research purposes, and they could request to be exempted from this study as per French law (non-interventional research).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bokov, P., Boujemla, I., Dahan, J. et al. Obstructive sleep apnea in children with Down syndrome: contribution of upper airway and chemosensitivity. Pediatr Res 94, 1990–1997 (2023). https://doi.org/10.1038/s41390-023-02718-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-023-02718-8
- Springer Nature America, Inc.